Cargando…
Correction to: miR-330-5p targets SPRY2 to promote hepatocellular carcinoma progression via MAPK/ERK signaling
Autores principales: | Xiao, Shuai, Yang, Mengyuan, Yang, Hao, Chang, Ruimin, Fang, Feng, Yang, Lianyue |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8277786/ https://www.ncbi.nlm.nih.gov/pubmed/34257271 http://dx.doi.org/10.1038/s41389-021-00340-z |
Ejemplares similares
-
miR-330-5p targets SPRY2 to promote hepatocellular carcinoma progression via MAPK/ERK signaling
por: Xiao, Shuai, et al.
Publicado: (2018) -
Correction to: MicroRNA-330-3p promotes cell invasion and metastasis in non-small cell lung cancer through GRIA3 by activating MAPK/ERK signaling pathway
por: Wei, Chun-Hua, et al.
Publicado: (2018) -
Vildagliptin Attenuates Myocardial Dysfunction and Restores Autophagy via miR-21/SPRY1/ERK in Diabetic Mice Heart
por: Li, Xiaochen, et al.
Publicado: (2021) -
Correction to: miR-182-5p promotes hepatocellular carcinoma progression by repressing FOXO3a
por: Cao, Man-Qing, et al.
Publicado: (2018) -
Correction: Spry1 Is Expressed in Hemangioblasts and Negatively Regulates Primitive Hematopoiesis and Endothelial Cell Function
por: Yang, Xuehui, et al.
Publicado: (2012)